Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Say what you will about dividends:

I can't agree with your statement that the decision to issue dividends had "nothing to do with" retail shareholders. We were all paid dividends and some of us bought more shares before and after the dividends were issued as a result. How could it have "nothing" to do with us? I think I get that you are suggesting that the warrant holders (mainly S&L) benefited with those dividends. Are you guys still on that subject? That is water long under the bridge with the agreement to retire the warrants last year. Old news! Now a dividend would be ALL about retail holders of the stock. Would it not?

Share
New Message
Please login to post a reply